Last week Thursday, an FDA advisory panel recommended the approval of Novo Nordisk’s injectable drug liraglutide for the treatment of obesity.

Discover the Science of Health
Last week Thursday, an FDA advisory panel recommended the approval of Novo Nordisk’s injectable drug liraglutide for the treatment of obesity.
You’ve probably heard that 8 hours is the magical amount of sleep needed every night. New research suggests that may not be the optimal amount for everyone.
A new review summarizing what is known about economic factors linked to increasing obesity in the United States dispels some widely held beliefs and concludes that cheap food has fueled the obesity epidemic [1].
This week is National Public Health Week (NPHW). During the first full week of April every year, National Public Health Week recognizes the contributions of public health and highlights issues that are important to improving our nation. The theme for National Public Health Week (NPHW) 2014 — Public Health: Start Here – will draw the nation’s attention to topics including school nutrition, disaster preparedness, prevention, food safety and community health.
Around the world, obesity levels are rising. For the first time in history, more people are overweight than undernourished. Premiering Friday, April 4th through Sunday, April 20th on BBC World News, a 3-part documentary series entitled “The Men Who Made Us Fat” explores the political, economic and social events that led to our increasingly overweight world.
Advertising Policy | Advertise with Highlight HEALTH
Disclaimer | Highlight HEALTH Privacy Policy
Copyright © 2025 Highlight Health Media